ICU Medical (ICUI) was upgraded from “Neutral” to “Buy” by Roth Capital on Tuesday, November 11, 2014. The firm currently has a $82.00 price target on the stock. Roth cited improved commercial execution in 2015 and operating leverage driven by operational and cost efficiency initiatives.
ICU Medical, Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications.
— ICU Medical, Inc. (@ICU_Medical) November 1, 2014